SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : BioLase Technology, Inc. (BLTI)

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Karl Drobnic who wrote (475)1/11/1999 10:09:00 AM
From: J Stone  Read Replies (1) of 706
 
Here's some decent news for a change. I'd have liked some specific dollar amounts though...

BIOLASE Technology Announces Record Setting Sales Month
Monday, January 11, 1999 08:30 AM Mail this article to a friend new!

SAN CLEMENTE, Calif.--(BW HealthWire)--Jan. 11, 1999--BIOLASE Technology, Inc. (Nasdaq:BLTI) today announced record sales.

For the month ended Dec. 31, 1998, BIOLASE reported that it achieved the highest level of sales ever in a single month. The company also announced that it will be releasing its fourth quarter sales before the current month end.

"This record sales month represents a significant but modest step towards our goals for 1999," stated Jeffrey W. Jones, president and chief executive officer of BIOLASE. Jones continued, "The December sales reflect a balanced mix of domestic direct customers and international sales."

BIOLASE Technology, Inc. manufactures and markets advanced cosmetic, aesthetic, dental and surgical products, including laser systems, HydroKinetic(TM) surgical cutting systems and other laser and non-laser based products for the professional and home consumer markets. The company's products incorporate patented and patent-pending technologies that permit achieving results in unique ways.

The matters discussed in this news release include forward-looking statements which are subject to various risks, uncertainties and other factors that could cause actual results to differ materially from the results anticipated in such forward-looking statements. Such risks, uncertainties and other factors include, but are not limited to, the effect of actions of third parties, including governmental officials, the timely development and acceptance of new products, the impact of competitive products and pricing, and other risks detailed from time-to-time in the company's filings with the Securities and Exchange Commission, including the reports on Forms 10-K and 10-Q. These forward-looking statements represent the company's judgment as of the date of this release. The company disclaims, however, any intent or obligation to update these forward-looking statements.

CONTACT: BIOLASE Technology, Inc. Jeffrey W. Jones, 949/361-1200 or Pacific Consulting Group, Inc. Scott Liolios, 949/574-3860

Quote for referenced ticker symbols: BLTI

© 1999, Business Wire
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext